Screening compound: C26H30N4O2S (D322-0218)

Screening compound: C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>S (D322-0218)
Screening compound: C<sub>26</sub>H<sub>30</sub>N<sub>4</sub>O<sub>2</sub>S (D322-0218) alternative view

Chemical Structure Depiction of ChemDiv screening compound
C26H30N4O2S (D322-0218)

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

D322-0218

Molecular Formula

C26H30N4O2S (C26 H30 N4 O2 S)

Compound Name

2-(4-methoxyphenyl)-4-(thiophene-2-carbonyl)-4a,5,6,7,8,8a-hexahydro-4H-spiro[[1,2,4]triazolo[3,2-b]quinazoline-9,1'-cyclohexane]

IUPAC name

(4aS8aR)-2-(4-methoxyphenyl)-4-(thiophene-2-carbonyl)-4a56788a-hexahydro-4H-spiro[[124]triazolo[32-b]quinazoline-91'-cyclohexane]

SMILES

COc(cc1)ccc1-c1nn(C2(CCCCC2)[C@H](CCCC2)[C@H]2N2C(c3cccs3)=O)c2n1

InChI

InChI=1S/C26H30N4O2S/c1-32-19-13-11-18(12-14-19)23-27-25-29(24(31)22-10-7-17-33-22)21-9-4-3-8-20(21)26(30(25)28-23)15-5-2-6-16-26/h7,10-14,17,20-21H,2-6,8-9,15-16H2,1H3/t20-,21-/m0/s1

InChI Key

NLCDKJWGFXPQNZ-SFTDATJTSA-N

MDL Number (MFCD)

C26H30N4O2S (D322-0218) in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Anti-infective Library (19449 compounds)

Antiviral HBV Library (10007 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

KRAS-Targeted Library (16000 compounds)

Protein-Protein Interaction Library (218420 compounds)

SmartTM Library (51161 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
  • Infections
  • Immune system
  • animal
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Cyclic compounds
  • Cyclic compounds

References: we are preparing a list of scientific research reports with C26H30N4O2S (D322-0218) chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound C26H30N4O2S (D322-0218)?
Check Price and Availability of C26H30N4O2S (D322-0218), then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of C26H30N4O2S (D322-0218) you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for C26H30N4O2S (D322-0218)
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for C26H30N4O2S (D322-0218)
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of C26H30N4O2S (D322-0218) available by request